Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
Cureus · 2026-04-12
DOI: 10.7759/cureus.106907 ↗At a glance
Fallbericht in Cureus, published on 2026-04-12. Written by Anushareddy Muddasani and 3 co-authors. Institution: Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA. 22 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pharmacology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pathology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, USA.
Cite
APA
Muddasani, A., Hendrix, R. J., Laudadio, J., & Gentille, C. (2026). Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. https://doi.org/10.7759/cureus.106907
Vancouver
Muddasani A, Hendrix RJ, Laudadio J, Gentille C. Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. 2026. doi:10.7759/cureus.106907
BibTeX
@article{Muddasani2026,
author = {Muddasani, Anushareddy and Hendrix, Rachel J and Laudadio, Jennifer and Gentille, Cesar},
title = {Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106907}
}
EUVIMED